Ive been right about Tesla (NASDAQ:TSLA) thus far.
There seem to be only two schools on Tesla. You either love the carmaker, or you hate it with a passion. I fall into the latter category, not because I’m anti clean energy, or opposed to new entries to the auto industry, but because of the grandiose and inefficient management history the company has had under Elon Musk. Ive written often about the competition and general cutthroat nature of the auto industry that Tesla faces. Ive been waiting for some time to see signs of Teslas inability to ramp up car production in a way that justifies its wild stock valuation. And boy howdy have I taken some flak in the comments section.
This week has given me some vindication on my feelings about Tesla. The stock is down on rough news of production complications, and a fading faith in Elon Musks rhetoric, something I said would happen. The valuation is not justified, and cannot be justified when youre selling such a small amount of cars and not turning any profit. I get it that this stock performance is about future potential earnings, but the company is not putting together concrete evidence that it is working toward those types of numbers.
Best Clean Energy Stocks To Watch For 2019: Piedmont Natural Gas Company Inc.(PNY)
- [By WWW.KIPLINGER.COM]
Duke also recently has expanded on its natural gas efforts, and will add numerous more natural gas customers when its buy-out of Piedmont Natural Gas Company, Inc. (PNY) goes through.
Best Clean Energy Stocks To Watch For 2019: Merrimack Pharmaceuticals, Inc.(MACK)
- [By Peter Graham]
The Q4 2016 earnings report for small cap cancer stock Merrimack Pharmaceuticals Inc (NASDAQ: MACK) is scheduled for before the market opens on Wednesday (March 1st). In early January, Merrimack Pharmaceuticals reportedadefinitive asset purchase and sale agreement with Ipsen SA (EPA: IPN; IPSEY) for a transaction valued at up to $1.025 billion (plus up to $33 million in net milestone payments retained by Merrimack pursuant to Merrimack’s exclusive licensing agreement with Shire) under which Merrimack will:
- [By Lisa Levin] Gainers
Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
- [By Paul Ausick]
Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) dropped about 19% on Wednesday to post a new 52-week low of $4.35 against a 52-week high of $9.02 and a Tuesday close of $5.37. Volume of nearly 11 million was more than 3 times the daily average of around 3.4 million. The company said this morning that it is ending its breast cancer treatment study.
Best Clean Energy Stocks To Watch For 2019: MDC Partners Inc.(MDCA)
- [By Lisa Levin]
MDC Partners Inc (NASDAQ: MDCA) shares dropped 60 percent to $3.38. MDC Partners reported a Q3 loss of $0.64 per share on revenue of $349.3 million.
- [By Logan Wallace]
Get a free copy of the Zacks research report on MDC Partners (MDCA)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Lisa Levin]
Shares of MDC Partners Inc (NASDAQ: MDCA) were down 31 percent to $12.52 after the company posted downbeat quarterly results and lowered its FY16 sales outlook.
- [By ]
In particular, Birchenough notes that he has increased confidence in the results due for Aeglea’s lead product candidate pegzilarginase- an enzyme replacement therapy for the treatment of Arginase deficiency and solid tumors.
MDC Partners (MDCA) Current share price: $7.55
Keep a close eye on MDC Partners- a fast-growing marketing and communications network. Most interestingly, MDC has just been upgraded by five-star Wells Fargo analyst Peter Stabler. His shift in sentiment comes with a bullish $11 price target (46% upside potential).
Best Clean Energy Stocks To Watch For 2019: PIMCO 25+ Year Zero Coupon US Trs ETF (ZROZ)
- [By Todd Shriber, ETF Professor]
Investors with a taste more rate-sensitive bond ETF may want to consider the PIMCO 25 Yr Zro Cupn US Ty Inx Fd ETF (NYSE: ZROZ) and the Vanguard Extended Duration ETF (NYSE: EDV).